论文信息 - A phase II study of AZD2171 (cediranib) in the treatment of patients with acute myeloid leukemia or high-risk myelodysplastic syndrome - 字舞流文

A phase II study of AZD2171 (cediranib) in the treatment of patients with acute myeloid leukemia or high-risk myelodysplastic syndrome

C. Erlichman | P. Flynn | B. Laplant | A. Moreno-Aspitia | M. Juckett | R. Mattison | A. Jumonville